Desmopressin : safety considerations in patients with chronic renal disease
- PMID: 16808548
- DOI: 10.2165/00002018-200629070-00001
Desmopressin : safety considerations in patients with chronic renal disease
Similar articles
-
Desmopressin 30 years in clinical use: a safety review.Curr Drug Saf. 2007 Sep;2(3):232-8. doi: 10.2174/157488607781668891. Curr Drug Saf. 2007. PMID: 18690973 Review.
-
Desmopressin (Nocdurna and Noctiva) for nocturnal polyuria.Med Lett Drugs Ther. 2019 Mar 25;61(1568):46-48. Med Lett Drugs Ther. 2019. PMID: 31022158 Review. No abstract available.
-
Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:115-23. Pediatr Endocrinol Rev. 2004. PMID: 16456490 Review.
-
Severe Hyponatremia After Desmopressin Diacetate Arginine Vasopressin Infusion in an Older Woman.J Am Geriatr Soc. 2016 May;64(5):1138-9. doi: 10.1111/jgs.14094. J Am Geriatr Soc. 2016. PMID: 27225368 No abstract available.
-
Role of Desmopressin in the Critical Care Setting.AACN Adv Crit Care. 2020 Mar 15;31(1):5-11. doi: 10.4037/aacnacc2020815. AACN Adv Crit Care. 2020. PMID: 32168509 Review. No abstract available.
Cited by
-
Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?Clin J Am Soc Nephrol. 2013 Apr;8(4):665-74. doi: 10.2215/CJN.06790712. Epub 2012 Sep 27. Clin J Am Soc Nephrol. 2013. PMID: 23024160 Free PMC article. Review.
-
Oral blood pressure augmenting agents for intravenous vasopressor weaning.World J Clin Cases. 2024 Dec 26;12(36):6892-6904. doi: 10.12998/wjcc.v12.i36.6892. World J Clin Cases. 2024. PMID: 39726934 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical